Hudson Bay Capital Management
TTPH

Hudson Bay Capital Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Hudson Bay Capital Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-250,000
Closed -$320K – 663
2020
Q1 		$320K Buy
+250,000
New +$510K 0.01% 387
2018
Q2 		– Sell
-7,900
Closed -$485K – 1042
2018
Q1 		$485K Sell
7,900
-17,100
-68% -$1.5M 0.01% 672
2017
Q4 		$3.15M Sell
25,000
-3,000
-11% -$384K 0.07% 239
2017
Q3 		$3.83M Buy
28,000
+14,266
+104% +$1.91M 0.1% 178
2017
Q2 		$1.96M Buy
+13,734
New +$2.12M 0.04% 342

Other funds holding TTPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Hudson Bay Capital Management's TTPH Position: Q2 2020 in Review

Hudson Bay Capital Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2020, closing a stake of 250,000 shares — an estimated $320K sold.

Hudson Bay Capital Management first reported a position in TTPH in Q2 2017 and held it in 5 quarters. The position peaked at $3.83M in Q3 2017. 26 funds tracked by Wall St. Rank hold TTPH as of Q2 2020.

  • Hudson Bay Capital Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Hudson Bay Capital Management sold 250,000 Tetraphase Pharmaceuticals, Inc. shares in Q2 2020, an estimated $320K.
  • Hudson Bay Capital Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2017 and held it in 5 quarters.
  • Hudson Bay Capital Management's Tetraphase Pharmaceuticals, Inc. position peaked at $3.83M in Q3 2017.
  • 26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2020.

Based on Hudson Bay Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.